Literature DB >> 21310664

Primed status of transitional B cells associated with their presence in the cerebrospinal fluid in early phases of multiple sclerosis.

Catalina Lee-Chang1, Isabelle Top, Hélène Zéphir, Sylvain Dubucquoi, Jacques Trauet, Patricia Dussart, Lionel Prin, Patrick Vermersch.   

Abstract

In the present study we showed that transitional B cells of patients with clinically isolated syndrome (CIS) and relapsing-remitting multiple sclerosis (RR-MS) are reduced in the peripheral blood (PB) (5.5- and 3.7-fold, respectively). In addition, these cells appeared to up-regulate different integrins (α4 and β1). These observations were associated with a primed cellular status, confirmed by an increased proportion of circulating CD80(+) transitional B cells. Interestingly, these results correlate with presence of transitional B cells in the CSF. Furthermore, these cells were absent in the CSF of individuals with other inflammatory neurological disease, and their levels in paired PB and CD80 expression were normal. Altogether, our data revealed that a differential primed status of transitional B cells is a characteristic feature of early phases of MS disease, and this functional status is associated with the ability of these cells to cross the blood-CSF barrier.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310664     DOI: 10.1016/j.clim.2010.11.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

1.  High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.

Authors:  B Oxombre; C Lee-Chang; A Duhamel; M Toussaint; M Giroux; M Donnier-Maréchal; P Carato; D Lefranc; H Zéphir; L Prin; P Melnyk; P Vermersch
Journal:  Br J Pharmacol       Date:  2015-02-10       Impact factor: 8.739

Review 2.  Circulating immune cells in multiple sclerosis.

Authors:  A P Jones; A G Kermode; R M Lucas; W M Carroll; D Nolan; P H Hart
Journal:  Clin Exp Immunol       Date:  2016-11-02       Impact factor: 4.330

3.  Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

Authors:  J Sellner; W Koczi; A Harrer; K Oppermann; E Obregon-Castrillo; G Pilz; P Wipfler; S Afazel; E Haschke-Becher; E Trinka; J Kraus
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

4.  Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.

Authors:  A J Ligocki; W H Rounds; E M Cameron; C T Harp; E M Frohman; A M Courtney; S Vernino; L G Cowell; B Greenberg; N L Monson
Journal:  Genes Immun       Date:  2013-04-18       Impact factor: 2.676

5.  B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.

Authors:  Heather L Wilson
Journal:  Biologics       Date:  2012-05-07

6.  Uptake and presentation of myelin basic protein by normal human B cells.

Authors:  Marie Klinge Brimnes; Bjarke Endel Hansen; Leif Kofoed Nielsen; Morten Hanefeld Dziegiel; Claus Henrik Nielsen
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

7.  Proinflammatory B-cell profile in the early phases of MS predicts an active disease.

Authors:  Thomas Guerrier; Myriam Labalette; David Launay; Catalina Lee-Chang; Olivier Outteryck; Guillaume Lefèvre; Patrick Vermersch; Sylvain Dubucquoi; Hélène Zéphir
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-12-22

8.  Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis.

Authors:  Anderson P Jones; Stephanie Trend; Scott N Byrne; Marzena J Fabis-Pedrini; Sian Geldenhuys; David Nolan; David R Booth; William M Carroll; Robyn M Lucas; Allan G Kermode; Prue H Hart
Journal:  Clin Transl Immunology       Date:  2017-05-26

Review 9.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

10.  Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.

Authors:  Serafeim Katsavos; Maria Anagnostouli
Journal:  Mult Scler Int       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.